In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
The 2023 American Society of Hematology (ASH) Annual Meeting and Exposition saw more than 7000 abstracts, with a focus placed on real-world data and practice-changing updates. A major theme of this year's meeting was a timely one: What can clinicians and researchers do to close persistent disparities in care and foster health equity?
An area of great need is multiple myeloma, with outcomes still far worse among Black patients in the United States compared with White patients despite potentially favorable cytogenetic disease characteristics and a plethora of novel treatments that have improved multiple myeloma outcomes overall.
In today's episode, Raymond Thertulien, MD, PhD, director of multiple myeloma and plasma cell disorders at Novant Health, is joined by Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, to discuss ASH 2023 data and the drivers of racial disparities in multiple myeloma outcomes. They spoke on a range of topics, including unacceptable gaps in access to the latest treatments, underuse of diagnostics such as cytogenetic testing, and society-level barriers to equitable care for Black patients with multiple myeloma.
Listen above or through one of these podcast services:
Learning From Past Innovations to Advance Ventilation Use in Respiratory Conditions
May 21st 2024In a keynote presentation at ATS 2024, Hannah Wunsch, MD, MSc, of Weill Cornell Medicine, delved into how the history of breathing support dating back to the 1700s has set the stage for ventilation advances still being made today.
Read More
Surgery, Chemotherapy Considered Protective Survival Factors in Patients With OC, Liver Metastases
May 21st 2024Surgery and chemotherapy significantly improved both overall survival (OS) and cancer-specific survival (CSS) in patients with liver metastases originating from ovarian cancer (OC), who generally face a poor prognosis with a 5-year survival rate of less than 30%.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Exploring Critical Advances in ARDS, Asthma, Lung Cancer, Health Equity at ATS 2024
May 20th 2024During a session at the American Thoracic Society (ATS) 2024 International Conference, experts presented the most impactful data from the last year on acute respiratory distress syndrome (ARDS), childhood asthma, health equity, and lung cancer.
Read More